Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cell Based Delivery receives NIST grant for cardiovascular program

Jan. 3, 2000

Benzofurans with cardioprotective, anxiolytic activity designed at Egis

Dec. 30, 1999

Potent, nonpeptide angiotensin II receptor antagonists discovered at Chinese university

Dec. 30, 1999

AstraZeneca seeks approval of Atacand HCT in the U.S.

Dec. 30, 1999

Schwarz, ARYx team up to design novel antiarrhythmic drugs

Dec. 30, 1999

CytRx announces Flocor phase III results

Dec. 28, 1999

Opioid receptor ligands from Novo Nordisk useful for vasomotor disturbances

Dec. 27, 1999

Scios's new p38 MAP kinase inhibitors especially useful for cardiovascular disorders

Dec. 27, 1999

Cardioprotective efficacy of NHE-1 inhibitor is superior to that of IPC

Dec. 27, 1999

Myogen achieves financing for oral enoximone pivotal trial

Dec. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...